ISHARES TR's ticker is CRBN and the CUSIP is 46434V464. A total of 80 filers reported holding ISHARES TR in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $729,000 | -3.2% | 4,835 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $753,000 | +5.6% | 4,814 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $713,000 | +8.4% | 4,814 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $658,000 | +112.9% | 4,764 | +93.8% | 0.00% | +100.0% |
| Q3 2022 | $309,000 | -8.6% | 2,458 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $338,000 | -22.3% | 2,480 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $435,000 | -5.6% | 2,655 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $461,000 | +6.2% | 2,639 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $434,000 | +8.2% | 2,631 | +8.9% | 0.00% | 0.0% |
| Q2 2021 | $401,000 | +40.2% | 2,415 | +31.8% | 0.00% | 0.0% |
| Q1 2021 | $286,000 | +7.1% | 1,833 | +2.1% | 0.00% | 0.0% |
| Q4 2020 | $267,000 | -2.6% | 1,796 | -14.3% | 0.00% | 0.0% |
| Q3 2020 | $274,000 | +8.7% | 2,095 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $252,000 | +18.3% | 2,072 | -0.5% | 0.00% | 0.0% |
| Q1 2020 | $213,000 | -16.1% | 2,082 | +6.4% | 0.00% | -50.0% |
| Q4 2019 | $254,000 | +18.7% | 1,957 | +9.8% | 0.00% | +100.0% |
| Q3 2019 | $214,000 | +3.4% | 1,782 | +2.9% | 0.00% | 0.0% |
| Q2 2019 | $207,000 | – | 1,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capricorn Investment Group LLC | 521,645 | $85,169,000 | 9.98% |
| Investure, LLC | 362,505 | $59,186,000 | 8.08% |
| Northland Capital Management LLC | 27,225 | $4,445,000 | 4.42% |
| FLOW TRADERS U.S. LLC | 373,512 | $60,983,000 | 2.10% |
| BSW Wealth Partners | 49,336 | $8,055,000 | 2.04% |
| University of Maryland Foundation, Inc. | 10,000 | $1,633,000 | 1.97% |
| Stonehearth Capital Management, LLC | 12,492 | $2,040,000 | 1.06% |
| Betterment LLC | 1,061,769 | $173,355,000 | 0.55% |
| Bond & Devick Financial Network, Inc. | 3,946 | $644,000 | 0.52% |
| EXANE DERIVATIVES | 9,813 | $1,602,070,000 | 0.45% |